Provider review
LifeMD
Full primary-care telehealth with GLP-1 — the pick for patients who want ongoing PCP integration.
- 4.30/5 rating
- From $249.00/mo
- 51 states
- 3 GLP-1s
- Accepts insurance
Rating breakdown
How this provider scored, per dimension
Editorial scores out of 5 — see our scoring rubric for the criteria behind each axis.
- Overall
- 4.3/5
- Pricing
- 4.0/5
- Patient experience
- 4.4/5
- Delivery speed
- 4.3/5
- Customer support
- 4.5/5
- Billing clarity
- 4.2/5
Pricing tiers
How LifeMD prices its plans
- Intro
$249
first month
Lowest tier
Start intro(opens affiliate page in a new tab) - Annual
$289
/mo, paid yearly
Start annual(opens affiliate page in a new tab) - Monthly
$329
/mo, month-to-month
Start monthly(opens affiliate page in a new tab)
Prices reflect LifeMD's published rates at most-recent editorial review. Programs change without notice — verify on the provider site before signup.

We earn a commission if you sign up through this link. Editorial ranking is independent.
What we liked
- Full primary-care model — same provider handles GLP-1 + BP + labs
- Insurance-accepting for the PCP visit component (drug still cash-heavy)
- Part of Novo Nordisk Wegovy-subscription cohort (2026)
What gave us pause
- Membership fee stacks on top of the medication cost
- Not the cheapest headline; positioning is care depth, not price
- GLP-1 access via primary-care wrapper, so slower than pure-med telehealth
Reader reviews
Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.
No user reviews yet
Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.
Ready to try LifeMD?
From $249.00/mo. Commission-funded, editorially independent.
Get started with LifeMDCommon questions readers ask
- How much does Wegovy cost without insurance?
- List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone). Full evidence-graded answer
- Does insurance cover Zepbound?
- Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares. Full evidence-graded answer
- Is Ozempic the same as Wegovy?
- Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different. Full evidence-graded answer
- Can I still get compounded GLP-1 in 2026?
- For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested. Full evidence-graded answer
- How does Wegovy compare to Saxenda?
- Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17. Full evidence-graded answer
Was this page helpful?